This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (471)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joanna E. Siegel, ScD; Milton C. Weinstein, PhD; Louise B. Russell, PhD; Marthe R. Gold, MD, MPH

JAMA. 1996;276(16):1339-1341.

Abstract
Objective.
—This article, the third in a 3-part series, describes recommendations for the reporting of cost-effective analyses (CEAs) intended to improve the quality and accessibility of CEA reports.

Participants.
—The Panel on Cost-Effectiveness in Health and Medicine, a nonfederal panel with expertise in CEA, clinical medicine, ethics, and health outcomes measurement, convened by the US Public Health Service.

Evidence.
—The panel reviewed the theoretical foundations of CEA, current practices, alternative methods, published critiques of CEAs, and criticisms of general CEA methods and reporting practices.

Consensus Process.
—The panel developed recommendations through 21/2 years of discussions. Comments on preliminary drafts were solicited from federal government methodologists, health agency officials, and academic methodologists.

Conclusion.
—These recommendations are proposed to enhance the transparency of study methods, assist analysts in providing complete information, and facilitate the presentation of comparable cost-effectiveness results across studies. Adherence to reporting conventions and attention to providing information required to understand and interpret study results will improve the relevance and accessibility of CEAs.

Author Affiliations
for the Panel on Cost-Effectiveness in Health and Medicine

From the Departments of Maternal and Child Health (Dr Siegel) and Health Policy and Management (Dr Weinstein), Harvard School of Public Health, Boston, Mass; the Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ (Dr Russell); and the Office of Disease Prevention and Health Promotion, US Public Health Service, Washington, DC (Dr Gold).

Footnotes
A complete list of the Panel on Cost-Effectiveness in Health and Medicine membership and staff appears at the end of this article.

Corresponding author: Marthe Gold, MD, MPH, Office of Disease Prevention and Health Promotion, 200 Independence Ave SW, Room 738G, Washington, DC 20201.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CT Coronary Angiography in Patients Suspected of Having Coronary Artery Disease: Decision Making from Various Perspectives in the Face of Uncertainty
Genders et al.
Radiology 2009;253:734-744.
ABSTRACT | FULL TEXT  

Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study.
Shaw et al.
J Am Coll Cardiol 2009;54:1258-1267.
ABSTRACT | FULL TEXT  

Using Observational Data for Decision Analysis and Economic Analysis
Brauer and Bozic
JBJS 2009;91:73-79.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study
Rogowski
Med Decis Making 2009;29:224-238.
ABSTRACT  

Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome
Brown et al.
Arch Ophthalmol 2009;127:146-152.
ABSTRACT | FULL TEXT  

Cost, Effectiveness, and Cost-Effectiveness
Diamond and Kaul
Circ Cardiovasc Qual Outcomes 2009;2:49-54.
FULL TEXT  

Cost-Effectiveness of Spine Surgery: The Jury Is Out
Katz and Losina
ANN INTERN MED 2008;149:901-903.
FULL TEXT  

Twenty Years of Cost-effectiveness Analysis in Medical Imaging: Are We Improving?
Otero et al.
Radiology 2008;249:917-925.
ABSTRACT | FULL TEXT  

Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
Shih and Halpern
CA Cancer J Clin 2008;58:231-244.
ABSTRACT | FULL TEXT  

Cost-Effectiveness Analysis of Periacetabular Osteotomy
Sharifi et al.
JBJS 2008;90:1447-1456.
ABSTRACT | FULL TEXT  

Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management
Jackson et al.
Arch Ophthalmol 2008;126:493-499.
ABSTRACT | FULL TEXT  

Improving the Quality of Abstract Reporting for Phase I Cancer Trials
Strevel et al.
Clin. Cancer Res. 2008;14:1782-1787.
ABSTRACT | FULL TEXT  

Simplified Pharmacoeconomics of Critical Care and Severe Sepsis
Ernst et al.
J Intensive Care Med 2007;22:283-293.
ABSTRACT  

Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
Breidthardt et al.
Clin. Chem. 2007;53:1415-1422.
ABSTRACT | FULL TEXT  

The Economic Impact of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Pelham et al.
J Pediatr Psychol 2007;32:711-727.
ABSTRACT | FULL TEXT  

N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study
Moe et al.
Circulation 2007;115:3103-3110.
ABSTRACT | FULL TEXT  

An Economic Analysis of the Timing of Microsurgical Reconstruction in Brachial Plexus Birth Palsy
Brauer and Waters
JBJS 2007;89:970-978.
ABSTRACT | FULL TEXT  

Estimating Preference Scores in Conventional and Home Nocturnal Hemodialysis Patients
McFarlane et al.
CJASN 2007;2:477-483.
ABSTRACT | FULL TEXT  

Aspirin for the Primary Prevention of Cardiovascular Disease in Women: A Cost-Utility Analysis
Pignone et al.
Arch Intern Med 2007;167:290-295.
ABSTRACT | FULL TEXT  

Interpreting the Economic Literature in Oncology
Grusenmeyer and Wong
JCO 2007;25:196-202.
ABSTRACT | FULL TEXT  

Quality-of-Life Assessment When There Is a Loss of Income
Myers et al.
Med Decis Making 2007;27:27-33.
ABSTRACT  

In Reply
Smith et al.
JCO 2006;24:5616-5616.
FULL TEXT  

Peripheral Arterial Disease: Clinical and Cost Comparisons between Duplex US and Contrast-enhanced MR Angiography--A Multicenter Randomized Trial.
de Vries et al.
Radiology 2006;240:401-410.
ABSTRACT | FULL TEXT  

Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea.
Mueller et al.
Arch Intern Med 2006;166:1081-1087.
ABSTRACT | FULL TEXT  

Coronary artery disease and outcome in acute congestive heart failure
Purek et al.
Heart 2006;92:598-602.
ABSTRACT | FULL TEXT  

Quality Assessment of Published Health Economic Analyses from South America
Machado et al.
The Annals of Pharmacotherapy 2006;40:943-949.
ABSTRACT | FULL TEXT  

Lumbar Disc Disorders and Low-Back Pain: Socioeconomic Factors and Consequences
Katz
JBJS 2006;88:21-24.
ABSTRACT | FULL TEXT  

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.
Pignone et al.
ANN INTERN MED 2006;144:326-336.
ABSTRACT | FULL TEXT  

Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease
van der Palen et al.
Thorax 2006;61:29-33.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure
Angus et al.
Circulation 2005;112:3745-3753.
ABSTRACT | FULL TEXT  

Costs and Cost Effectiveness of a Health Care Provider-Directed Intervention to Promote Colorectal Cancer Screening Among Veterans
Wolf et al.
JCO 2005;23:8877-8883.
ABSTRACT | FULL TEXT  

Toward stronger evidence on quality improvement. Draft publication guidelines: the beginning of a consensus project
Davidoff and Batalden
Qual Saf Health Care 2005;14:319-325.
ABSTRACT | FULL TEXT  

Radiology Cost and Outcomes Studies: Standard Practice and Emerging Methods
Hollingworth
Am. J. Roentgenol. 2005;185:833-839.
FULL TEXT  

Decision Analysis and Simulation Modeling for Evaluating Diagnostic Tests on the Basis of Patient Outcomes
Plevritis
Am. J. Roentgenol. 2005;185:581-590.
FULL TEXT  

Quality of Abstracts of Papers Reporting Original Cost-Effectiveness Analyses
Rosen et al.
Med Decis Making 2005;25:424-428.
ABSTRACT  

Challenges in Systematic Reviews of Economic Analyses
Pignone et al.
ANN INTERN MED 2005;142:1073-1079.
ABSTRACT | FULL TEXT  

Cost-Utility Analyses in Orthopaedic Surgery
Brauer et al.
JBJS 2005;87:1253-1259.
ABSTRACT | FULL TEXT  

Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies
Gazelle et al.
Radiology 2005;235:361-370.
ABSTRACT | FULL TEXT  

Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II
Al-Khatib et al.
ANN INTERN MED 2005;142:593-600.
ABSTRACT | FULL TEXT  

Economic Study in Surgical Patients of a New Model of Nutrition Therapy Integrating Hospital and Home vs the Conventional Hospital Model
Baxter et al.
JPEN J Parenter Enteral Nutr 2005;29:S96-S105.
ABSTRACT | FULL TEXT  

Cost-Utility Analysis Studies of Depression Management: A Systematic Review
Pirraglia et al.
Am. J. Psychiatry 2004;161:2155-2162.
ABSTRACT | FULL TEXT  

Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection
Gazelle et al.
Radiology 2004;233:729-739.
ABSTRACT | FULL TEXT  

Measuring Economic Outcomes of Cancer
Fryback and Craig
J Natl Cancer Inst Monogr 2004;2004:134-141.
ABSTRACT | FULL TEXT  

Is a Charge a Cost If Nobody Pays It?
Engoren
Chest 2004;126:662-664.
FULL TEXT  

Quality of Abstracts Describing Randomized Trials in the Proceedings of American Society of Clinical Oncology Meetings: Guidelines for Improved Reporting
Krzyzanowska et al.
JCO 2004;22:1993-1999.
ABSTRACT | FULL TEXT  

Peripheral Vasculature: Whole-Body MR Angiography with Midfemoral Venous Compression--Initial Experience
Herborn et al.
Radiology 2004;230:872-878.
ABSTRACT | FULL TEXT  

Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea
Mueller et al.
NEJM 2004;350:647-654.
ABSTRACT | FULL TEXT  

Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease
Monninkhofe et al.
Chronic Respiratory Disease 2004;1:7-16.
ABSTRACT  

Quantitative analysis of sponsorship bias in economic studies of antidepressants
Baker et al.
Br. J. Psychiatry 2003;183:498-506.
ABSTRACT | FULL TEXT  

The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Eur Respir J 2003;22:1s-44s.
FULL TEXT  

Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis
Kushiya et al.
CLIN APPL THROMB HEMOST 2003;9:203-210.
ABSTRACT  

New Choices for Central Venous Catheters: Potential Financial Implications
Shorr et al.
Chest 2003;124:275-284.
ABSTRACT | FULL TEXT  

Task force #5--is atherosclerosis imaging cost effective?
Mark et al.
J Am Coll Cardiol 2003;41:1906-1917.
FULL TEXT  

The burden of illness and economic evaluation for COPD
Ramsey and Sullivan
Eur Respir J 2003;21:29S-35s.
ABSTRACT | FULL TEXT  

Chapter 15: Public Health Policy and Cost-Effectiveness Analysis
Goldie
J Natl Cancer Inst Monogr 2003;2003:102-110.
ABSTRACT | FULL TEXT  

Editorial I: Sedating patients undergoing mechanical ventilation in the intensive care unit--winds of change?
Kong and Bion
Br J Anaesth 2003;90:267-269.
FULL TEXT  

Pharmacoeconomic Implications of Large Multicenter Clinical Trials
Raisch et al.
The Annals of Pharmacotherapy 2003;37:447-450.
FULL TEXT  

Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis
Inadomi et al.
ANN INTERN MED 2003;138:176-186.
ABSTRACT | FULL TEXT  

Economic Evaluationin Orthopaedics
Bozic et al.
JBJS 2003;85:129-142.
FULL TEXT  

Atherosclerotic and Hemostatic Abnormalities in Patients Undergoing Hemodialysis
Kushiya et al.
CLIN APPL THROMB HEMOST 2003;9:53-60.
ABSTRACT  

Abdominal Aortic Aneurysms: Cost-effectiveness of Elective Endovascular and Open Surgical Repair
Bosch et al.
Radiology 2002;225:337-344.
ABSTRACT | FULL TEXT  

Comparison of Preference-Based Utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after Treatment of Patients with Intermittent Claudication
Bosch et al.
Med Decis Making 2002;22:403-409.
ABSTRACT  

Economic Analyses of Respiratory Syncytial Virus Immunoprophylaxis in High-Risk Infants: A Systematic Review
Kamal-Bahl et al.
Arch Pediatr Adolesc Med 2002;156:1034-1041.
ABSTRACT | FULL TEXT  

Quality of Systematic Reviews of Economic Evaluations in Health Care
Jefferson et al.
JAMA 2002;287:2809-2812.
ABSTRACT | FULL TEXT  

Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis
Eckman et al.
Med Decis Making 2002;22:108-124.
ABSTRACT  

Understanding Costs and Cost-Effectiveness in Critical Care . Report from the Second American Thoracic Society Workshop on Outcomes Research
Am. J. Respir. Crit. Care Med. 2002;165:540-550.
ABSTRACT | FULL TEXT  

Inclusion of drugs in provincial drug benefit programs: Who is making these decisions, and are they the right ones?
Laupacis
CMAJ 2002;166:44-47.
FULL TEXT  

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
Llovet et al.
Gut 2002;50:123-128.
ABSTRACT | FULL TEXT  

The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 {micro}g Twice a Day in Subjects with Obstructive Airway Disease . Results of the DIMCA Program
VAN DEN BOOM et al.
Am. J. Respir. Crit. Care Med. 2001;164:2057-2066.
ABSTRACT | FULL TEXT  

Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
Sanders et al.
ANN INTERN MED 2001;135:870-883.
ABSTRACT | FULL TEXT  

The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
Moher et al.
J. Am. Podiatr. Med. Assoc. 2001;91:437-442.
ABSTRACT | FULL TEXT  

Evidence-Based Risk Assessment in Noninvasive Imaging
Shaw et al.
JNM 2001;42:1424-1436.
ABSTRACT | FULL TEXT  

Cost-Effectiveness Analysis in Radiology
Singer and Applegate
Radiology 2001;219:611-620.
ABSTRACT | FULL TEXT  

The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
Moher et al.
JAMA 2001;285:1987-1991.
ABSTRACT | FULL TEXT  

The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
Moher et al.
ANN INTERN MED 2001;134:657-662.
ABSTRACT | FULL TEXT  

The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman et al.
ANN INTERN MED 2001;134:663-694.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Colorectal Cancer Screening
McMahon et al.
Radiology 2001;219:44-50.
ABSTRACT | FULL TEXT  

Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
Nichol
Arch Intern Med 2001;161:749-759.
ABSTRACT | FULL TEXT  

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
Bolondi et al.
Gut 2001;48:251-259.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines
Weaver et al.
Arch Intern Med 2001;161:111-120.
ABSTRACT | FULL TEXT  

Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model
Stigum et al.
Int J Epidemiol 2000;29:1076-1084.
ABSTRACT | FULL TEXT  

Cost-effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Sarasin et al.
Arch Intern Med 2000;160:2773-2778.
ABSTRACT | FULL TEXT  

Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection
Ross et al.
JAMA 2000;284:1399-1405.
ABSTRACT | FULL TEXT  

Systematic Overview of Cost-Utility Assessments in Oncology
Earle et al.
JCO 2000;18:3302-3317.
ABSTRACT | FULL TEXT  

Conference report: Oncology pharmacoeconomics The Seventh International Symposium on Oncology Pharmacy Practice, Prague, Czech Republic, April 5-8, 2000
Goldspiel
J Oncol Pharm Pract 2000;6:126-129.
 

THE LONG-TERM COST-EFFECTIVENESS OF IMPROVING ALCOHOL ABSTINENCE WITH ADJUVANT ACAMPROSATE
Palmer et al.
Alcohol Alcohol 2000;35:478-492.
ABSTRACT | FULL TEXT  

News from the International Committee of Medical Journal Editors
Davidoff
ANN INTERN MED 2000;133:229-231.
FULL TEXT  

The Quality of Reporting in Published Cost-Utility Analyses, 1976-1997
Neumann et al.
ANN INTERN MED 2000;132:964-972.
ABSTRACT | FULL TEXT  

Sedation in the Intensive Care Unit: A Systematic Review
Ostermann et al.
JAMA 2000;283:1451-1459.
ABSTRACT | FULL TEXT  

Analysis of Costs
Brown et al.
Arch Ophthalmol 2000;118:444-444.
FULL TEXT  

Cost Utility Analysis of Radiographic Screening for an Orbital Foreign Body before MR Imaging
Seidenwurm et al.
Am. J. Neuroradiol. 2000;21:426-433.
ABSTRACT | FULL TEXT  

Costing interventions in primary care
Kernick
Fam Pract 2000;17:66-70.
ABSTRACT | FULL TEXT  

Continuing Screening Mammography in Women Aged 70 to 79 Years: Impact on Life Expectancy and Cost-effectiveness
Kerlikowske et al.
JAMA 1999;282:2156-2163.
ABSTRACT | FULL TEXT  

The Effect of Acute Respiratory Distress Syndrome on Long-term Survival
DAVIDSON et al.
Am. J. Respir. Crit. Care Med. 1999;160:1838-1842.
ABSTRACT | FULL TEXT  

Interpreting, Integrating, and Individualizing Evidence about the Prevention of Diabetic Nephropathy
Cook and Guyatt
ANN INTERN MED 1999;131:707-708.
FULL TEXT